The success of Sildenafil initially fueled a surge for pharma, however recent changes present a complicated picture for shareholders. Lower-cost competitors are reducing revenue, and continued legal battles add more https://mathekisa113180.blogdigy.com/sildenafil-and-the-pharmaceutical-industry-a-risky-bet-66119432